InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Hyperfine, Inc.

HYPR Clue Score60
United States Fiscal year ends December CIK 0001833769
$0.93 -1.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.93 −90.63% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 27 Jan 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue0.3Operating income−23.5Net income−23.4Fiscal year 2021Revenue1.5 +408.8%Operating income−64.9Net income−64.9EPS, diluted−17.57Fiscal year 2022Revenue6.8 +355.5%Operating income−73.9Net income−44.2EPS, diluted−1.04Fiscal year 2023Revenue11.0 +61.9%Operating income−48.1Net income−44.2EPS, diluted−0.62Fiscal year 2024Revenue12.9 +16.8%Operating income−43.2Net income−40.7EPS, diluted−0.56Fiscal year 2025Revenue13.6 +5.2%Operating income−37.1Net income−35.6EPS, diluted−0.43
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.3 1.5 6.8 11.0 12.9 13.6
Growth +408.8% +355.5% +61.9% +16.8% +5.2%
Operating income −23.5 −64.9 −73.9 −48.1 −43.2 −37.1
Net income −23.4 −64.9 −44.2 −44.2 −40.7 −35.6
Growth
EPS, diluted n/a −17.57 −1.04 −0.62 −0.56 −0.43

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Gross margin−162.2%Operating margin−7,990.1%Net margin−7,968.4%Free cash flow margin−7,854.8%Fiscal year 2021Gross margin−78.0%Operating margin−4,336.1%Net margin−4,335.0%Free cash flow margin−3,335.1%Fiscal year 2022Gross margin13.3%Operating margin−1,084.2%Net margin−649.2%Free cash flow margin−1,070.2%Fiscal year 2023Gross margin43.1%Operating margin−436.1%Net margin−401.0%Free cash flow margin−386.3%Fiscal year 2024Gross margin45.7%Operating margin−335.3%Net margin−315.9%Free cash flow margin−303.7%Fiscal year 2025Gross margin49.8%Operating margin−273.4%Net margin−262.3%Free cash flow margin−214.8%
FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin −162.2% −78.0% 13.3% 43.1% 45.7% 49.8%
Operating margin −7,990.1% −4,336.1% −1,084.2% −436.1% −335.3% −273.4%
Net margin −7,968.4% −4,335.0% −649.2% −401.0% −315.9% −262.3%
Free cash flow margin −7,854.8% −3,335.1% −1,070.2% −386.3% −303.7% −214.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−21.5Capital expenditure−1.6Free cash flow−23.1Fiscal year 2021Operating cash flow−47.2Capital expenditure−2.7Free cash flow−49.9Fiscal year 2022Operating cash flow−72.3Capital expenditure−0.6Free cash flow−72.9Fiscal year 2023Operating cash flow−41.8Capital expenditure−0.8Free cash flow−42.6Fiscal year 2024Operating cash flow−38.8Capital expenditure−0.4Free cash flow−39.2Fiscal year 2025Operating cash flow−27.9Capital expenditure−1.2Free cash flow−29.1
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −21.5 −47.2 −72.3 −41.8 −38.8 −27.9
Capital expenditure −1.6 −2.7 −0.6 −0.8 −0.4 −1.2
Free cash flow −23.1 −49.9 −72.9 −42.6 −39.2 −29.1
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash62.7Shareholders’ equity−61.1Fiscal year 2021Cash188.5Shareholders’ equity186.2Fiscal year 2022Cash117.5Shareholders’ equity123.7Fiscal year 2023Cash75.2Shareholders’ equity84.4Fiscal year 2024Cash37.6Shareholders’ equity49.0Fiscal year 2025Cash35.1Total debt0.0Net cash (debt)35.1Shareholders’ equity41.0Debt to equity0.00
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 62.7 188.5 117.5 75.2 37.6 35.1
Total debt n/a n/a n/a n/a n/a 0.0
Net cash (debt) n/a n/a n/a n/a n/a 35.1
Shareholders’ equity −61.1 186.2 123.7 84.4 49.0 41.0
Debt to equity n/a n/a n/a n/a n/a 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.3 1.5 6.8 11.0 12.9 13.6
Growth +408.8% +355.5% +61.9% +16.8% +5.2%
0.8 2.7 5.9 6.3 7.0 6.8
−0.5 −1.2 0.9 4.8 5.9 6.8
Growth +424.5% +23.8% +14.6%
14.6 25.8 28.2 22.5 22.5 17.5
5.9 27.5 32.4 20.3 17.5 16.3
−23.5 −64.9 −73.9 −48.1 −43.2 −37.1
Growth
−23.4 −64.9 −73.2 −44.2 −40.7 −35.6
n/a 0.0 0.0 0.0 0.0 0.0
−23.4 −64.9 −44.2 −44.2 −40.7 −35.6
Growth
Per share
n/a −17.57 −1.04 −0.62 −0.56 −0.43
n/a −17.57 −1.04 −0.62 −0.56 −0.43
Growth
n/a 3.7 70.4 71.3 72.4 81.8
n/a 3.7 70.4 71.3 72.4 81.8
Growth +1,808.9% +1.2% +1.5% +13.0%

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 115.2% a year over five years.
  • Operating margin is up 7,716.7 points on five years ago, at -273.4%.
  • A net loss in 6 of 6 years on file.